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Urinary tract infection is the most common human infection with a high morbidity. In
primary care and hospital services, conventional urine culture is a key part of infection
diagnosis but results take at least 24 h. Therefore, a rapid and reliable screening method
is still needed to discard negative samples as quickly as possible and to reduce
the laboratory workload. In this aspect, this study aims to compare the diagnostic
performance between Sysmex UF-1000i and FUS200 systems in comparison to urine
culture as the gold standard. FromMarch to June 2016, 1,220 urine samples collected at
the clinical microbiology laboratory of the “Miguel Servet” hospital were studied in parallel
with both analysers, and some technical features were evaluated to select the ideal
equipment. The most balanced cut-off values taking into account bacteria or leukocyte
counts were 138 bacteria/µL or 119.8 leukocyte/µL for the UF-1000i (95.3% SE and
70.4% SP), and 5.7 bacteria/µL or 4.3 leukocyte/µL for the FUS200 (95.8% SE and
44.4% SP). The reduction of cultured plates was 37.4% with the FUS200 and 58.3%
with the UF-1000i. This study shows that both techniques improve the workflow in the
laboratory, but the UF-1000i has the highest specificity at any sensitivity and the FUS200
needs a shorter processing time.
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INTRODUCTION
Urinary tract infections (UTIs) are the most frequent infections diagnosed in hospitalized patients
and primary care centres. They are associated with a high morbidity and cost (1–4). Therefore,
urinalysis is one of the most important in vitro diagnostic tests in laboratory practice for the
diagnosis of UTIs (2).
Urine culture and identification remain the gold standard procedures for definitive diagnosis
of UTIs, but it is laborious, expensive, and has a response time of 24–48 h (5–9). Therefore, a
rapid and reliable screeningmethod would be useful to detect negative samples, avoiding costly and
laborious culture procedures and reducing the total analysis time (8, 10). To avoid misclassification
of positive urine samples, high sensitivity and negative predictive values are prerequisites for a
screening method (1, 11). European Urinalysis Guidelines recommend an analytical sensitivity
higher than 90–95% to detect asymptomatic bacteriuria at 105 colony-forming unit/millilitre
(CFU/mL) (12, 13).
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UTIs screening is currently being carried out using
automated and cost-effective diagnostic devices, including
automated microscopy (IQ200), hybridization with fluorescent
probes (Cellenium 160 US), measurement of bacterial ATP
by enzymatic reaction (Coral UTI Screen), Flow Imaging
Microscopy (FUS200), and flow cytometry (Sysmex UF-1000i)
(6, 14). In our laboratory, we culture 300 urine samples every day
and more than half of the plates are negative or contaminated.
In terms of workload and costs, this means more than 2 h of
faculty work and 2,000 euros per month. Previous research has
reported a decrease in the number of samples cultured with
highly sensitive screening systems such as flow cytometry (10).
Automatic screening methods have been compared with other
dipstick methods such as UriSed, Clinitek Atlas, Urisys 2,400,
and Aution Max (3, 15, 16). However, only a few studies have
compared different automated techniques for the screening of
UTIs using bacterial and leukocyte counts (4, 17).
Geerts et al. (8) reported that the UF-1000i, developed to
standardize sediment analysis in urine, rapidly quantifies urine
particles, including leukocytes or white blood cells (WBCs),
bacteria, red blood cells (RBCs), and casts by scattering and
fluorescence. This instrument is a urine flow cytometer that
utilizes a diode laser to quantify the sediment in two analytic
channels using a fluorescent dye, which stains DNA. One
of the channels analyses only the microbial content of the
urine, while the other analyses RBCs, WBCs, casts, and other
non-microbial sediments (18). After staining, the particles are
transported to a flow cell and irradiated with a laser (λ
635 nm). On the other hand, Kocer et al. (5) described the
FUS200 as an instrument whose measurement principles are
based on flow imaging microscopy. This instrument is capable
of detecting and counting settled particles using the sheath
flow technique. Under the effect of a double layer sheath,
the urine sample enters the flow cell in the form of a single
cell layer. The FUS200 CCD camera captures 650 frames
of images. All images are evaluated by high quality image
processing software capable of detecting and classifying urine
particles.
In this article, we compared two different fast-automated
systems, the UF-1000i and the FUS200, to select the most suitable
screening equipment to meet the needs of the laboratory. For this
purpose, we employed the semi-quantitative urine culture as the
reference method to analyse the capacity of both systems for the
diagnosis of UTIs in a tertiary hospital.
MATERIALS AND METHODS
Collection of Urine Specimens and
Analysers
Between March and June 2016, 1,220 urine samples from
inpatients and outpatients were analysed in the clinical
microbiology laboratory at the “Miguel Servet” hospital, in
Zaragoza, Spain. The sample size was determined using the PASS
v13 software (NCSS Statistical Software) based on the Lin and
Fine et al. method, using a 95% sensitivity and an accuracy of 5%
for the prevalence UTI expected in our population. The Hospital
Committee of Ethic approved this study (reference number:
07/2016).
All urine specimens included in this study were cultured
and processed using the UF-1000i (Sysmex Corporation, Kobe,
Japan) and FUS200 (Dirui Industrial CO, LTD, China) analysers
within 24 h after collection, from Tuesday to Friday each week.
Voided midstream urine was collected in tubes with boric
acid. Samples were excluded from analysis if an inadequate
sample volume (<8mL) was provided or if excessive mucus,
gross haemolysis or pyuria were observed on visual inspection
to prevent blockage of the instrument or interference during
measurement.
Urine Culture
Prior to automated systems, 1 µL urine specimens were cultured
using the WASP R©DT: Walk-Away Specimen Processor (Copan
Diagnostics, Murrieta, CA) on Brilliance UTI agar (Oxoid Ltd.,
Basingstoke, United Kingdom). The cultures, incubated at 35◦C
for 18–24 h, were considered as positive if growth≥105 CFUs/ml.
We used MALDI-TOF analysis (MALDI Microflex LT, Bruker
Daltonics, Bremen, Germany) to identify growing colonies. If
there were three or more different types of colonies, the urine
was considered as contaminated, although we classified it as
negative for research purposes and it was not submitted to the
identification procedure.
Instrument Features
Some features to compare both systems and to select the best
equipment were: general features (such as size, weight, electrical
requirement, noise) and technical features (such as the number of
samples processed per hour, consumables, noise level, limitations
on the samples submitted, connectivity with the laboratory
software, maintenance, cost).
Data Analysis
Statistical analysis was performed using the SPSS R© 21.0
Statistical Packages (SPSS Inc., Chicago, Illinois, USA). In order
to determine the best cut-off values, the receiver operating
characteristic (ROC) curve technique was used for bacteria and
WBCs. Sensitivity (SE), specificity (SP), positive predictive value
(PPV), negative predictive value (NPV) and accuracy rate at the
best cut-off values for bacteria and WBCs were also calculated
considering the urine culture as the gold standard.
RESULTS
Screening of Significant Bacteriuria
One thousand and two hundred and twenty (1,220) urine
specimens were included, of which 213 (17.4%) were positive and
1,007 (82.6%) were negative. The majority of the specimens were
collected from women (58.4%). Outpatients represented 53.3%
(n = 650) and inpatients 46.7% (n = 570) of the subjects. The
most common microorganisms identified were Escherichia coli
(62%), E. faecalis (9.4%),K. pneumoniae (7%), coagulase-negative
Staphylococcus (5.6%), P. mirabilis (3.3%), E. cloacae (2.8%), P.
aeruginosa (2.8%), S. agalactiae (2.3%), C. freundii (0.9%), K.
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FIGURE 1 | ROC curve analysis for the UF-1000i. Using flow cytometry, the
AUC was 0.943 and 0.832 for bacterial and leukocyte count (>105 CFU/mL),
respectively.
oxytoca (0.9%), S. oralis (0.9%), E. aerogenes (0.5%), E. faecium
(0.5%), P. vulgaris (0.5%), and C. albicans (0.5%).
Ten samples were culture-positive but negative by the
UF-1000i (false negatives, 0.8%) at a cut-off value of 138.8
bacteria/µL or 119.8 leukocyte/µL. The bacteria isolated from
these ten samples were P. mirabilis (3); C. albicans (1); P. vulgaris
(1); E. faecalis (1); E. coli (1); P. aeruginosa (1); S. epidermidis (1);
and S. agalactiae (1). Nine false negative samples (0.7%) for the
FUS200 were found at a cut-off value of 5.73 bacteria/µL or 4.3
leukocyte/µL. The bacteria isolated from these nine samples were
P. mirabilis (3); E. coli (3); P. vulgaris (1); E. faecalis (1) and S.
agalactiae (1). From the nineteen false negative samples, seven
were identified by both methods: P. mirabilis (3); P. vulgaris (1);
E. faecalis (1); E. coli (1), and S. agalactiae (1).
Comparison of Diagnostic Accuracy and
ROC Curve Analysis
Figures 1, 2 show the results of the analysis of the ROC curve
carried out to assess the diagnostic value of bacteria and leukocyte
counts of the two automated systems. In general, the area under
the curve (AUC) for bacteria in the UF-1000i and the FUS200
performed better than the AUC for WBCs as a predictor of
culture results. The sensitivity, specificity, NPV and PPV at
different cut-off values for each method are shown in Table 1.
We analysed the best combinations of bacterial and WBC counts
as screening criteria to achieve the best sensitivity and specificity.
Themost balanced cut-off value for the UF-1000i and the FUS200
were 138 bacteria/µL or 119.8 leukocyte/µL, and 5.7 bacteria/µL
or 4.3 leukocyte/µL, respectively. These results indicate a similar
sensitivity of both systems; however, the UF-1000i showed a
better specificity.
The application of cut-off values of 138 bacteria/µL or 119.8
leukocyte/µL for the UF-1000i and 5.7 bacteria/µL or 4.3
leukocyte/µL for the FUS200 would have led to reductions of 58.3
FIGURE 2 | ROC curve analysis for the FUS200. Using flow microscopy, the
AUC was 0.864 and 0.834 for bacterial and leukocyte count (>105 CFU/mL),
respectively.
and 37.4% in the number of samples cultured, respectively. At the
same level of SE and NPV, the UF-1000i had higher SP and PPV.
Sample Processing Throughput
Significant differences were observed between the two automated
methods in the number of samples processed per hour, i.e.,
the UF-1000i processed 66 samples/hour (100 samples/hour
was processed in user’s guide) and the FUS200 processed 120
samples/hour (120 samples/hour was processed in user’s guide).
DISCUSSION
To perform rapid diagnostics of urinary tract infection, the use of
automated devices to screen urine samples is an attractive option,
and reduce the number of urine samples that will be cultured,
reduce costs and decrease the amount of antibiotics prescribed
unnecessarily (2, 10).
Bacterial counts of one or two microorganisms in the
same culture have been classically considered as an important
argument for the diagnosis or UTI. The presence of more than
two microorganisms means an inadequate sampling procedure
or a contaminated culture that in terms of our research was
considered as a negative result in both screening systems. In
contrast, there are studies that considered the contaminate
culture as positive result or excluded from the studies these
samples (6, 12, 19).
In our study, the AUC for bacteria was greater than the AUC
for leukocytes in both systems. These results agree with those
published by Broenen et al. (1) that showed a greater AUC
for bacterial counts (0.96 vs. 0.79 CFU/mL) than for leukocyte
counts. In addition, the corresponding sensitivity was higher
for bacteria than for leukocytes considering any specificity. Our
study shows greater specificity and sensitivity improvement for
the combined count of bacterial and leukocyte than for bacterial
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TABLE 1 | Performance of the Sysmex® UF-1000i and the FUS200 at different cut-off thresholds for leukocyte and bacterial counts.
AUC Cut-off value Se (%) Sp (%) PPV (%) NPV (%)
UF-1000i >105* Bacteria 0.943 89.4/µL 94.8 69.2 39.5 98.4
255.3/µL 90.1 79.6 48.8 97.4
WBC 0.832 3.8/µL 94.8 36.7 24.1 97.1
6.3/µL 90.1 51 28 96.1
Bac or WBC 138/µL−119.8/µL 95.3 70.4 40.5 98.6
29.5/µL−154.3/µL 97.6 52.7 30.4 99.1
>104* Bacteria 0.876 16.9/µL 95 42.6 31.1 96.9
29.5/µL 90 54.3 34.9 95.2
WBC 0.787 1.6/µL 95 13.7 23 91
3.9/µL 90 37.7 28.2 93.3
FUS200 >105* Bacteria 0.864 1.4/µL 95.8 45.3 27 98.1
2,86/µL 90.14 62.36 33.62 96.76
WBC 0.834 2.1/µL 93.9 33.4 22.9 96.3
4,3/µL 90.14 53.72 29.17 96.26
Bac or WBC 5.7/µL−4.3/µL 95.8 44.4 26.7 98
1.4/µL−4–3/µL 97.6 30 22.8 98.37
>104* Bacteria 0.798 0.72/µL 93.49 29.72 26.57 94.37
1.4/µL 88.50 45.35 30.59 93.54
WBC 0.792 1.4/µL 93.87 25.96 25.65 93.96
2.1/µL 90.04 33.79 27.01 92.57
*Value obtained in culture (CFU/mL).
TABLE 2 | Diagnostic yield of the cut-off points obtained in published studies.
Author/year System Cut-off point Se/Sp PPV/NPV






Yuksel (25) FUS100 *ND for WBC 68%/89% 60%/92%






De Rosa (12) UF-1000i 170 bac × 106/L and
150 WBC × 106/L
98.8%/76.5% 59.2%/99.5%
Jolkkonen (18) UF-500i Different cut-off points 93.4%/82.3% *ND
Pieretti (22) UF-1000i 65 bac/mL and 100 WBC/mL 98%/62% 53.7%/98.7%
Wang (23) UF-1000i bac>105/mL or WBC >56/µL or yeast-like fungi >100/µL 86%/95% 91%/94%










Broeren (1) UF-1000i 230 bac /µl 95%/80% *ND
Jiang (26) UF-1000i 230 bac/ µl 54%/96% 56%/96%
Marschal (4) UF-1000i bac 3 × 104/mL 80.9%/78% *ND
Muñoz-algarra (11) UF-1000i 50 bac/µL 91.3%/73.1% 67.6%/93.2%





UF-1000i 690 bac/µL and
38 WBC/µL
92%/65% 39%/97%
Okada (28) UF-50 *ND 83.1%/76.4% 62%/90.7%
*ND: No Data.
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count alone. However, some articles show not improvement of
screening with combined counts than bacteria alone (19, 20).
According to the reviewed literature, the cut-off values used
range from 25 to 230 bacteria/µL (2, 12, 18, 21–23). In our
study, the best cut-off point was found after comparing the
results of culture and bacterial or leukocyte count, and it was 138
bacteria/µL or 119.8 leukocyte/µL (SE 95.3%, SP 70.4%) with the
UF-1000i (24). This cut-off value had a similar SE and a higher SP
than the cut-off point obtained with the FUS200 (5.7 bacteria/µL
or 4.3 leukocyte/µL; 95.8% SE, 44.4% SP) (Table 2).
Few studies have compared different automated systems to
screen for UTI using bacterial and leukocyte counts. Marschal
et al. (4), compared the UroQuick, BACSYS-40i, and UF-
1000i systems. Only the UroQuick showed less sensitivity (73%)
but better specificity (92.8%) for the leukocyte count than
the bacterial count (SE 80.9%, SP 78%). Shayanfar et al. (17)
compared the Iris iQ200 and the UF-100. The Iris iQ200 showed
less sensitivity for leukocyte and bacteria cut-off (76 and 85%)
than the UF-100 (92 and 95%).
Our study shows that the cut-off point set for the UF-1000i
and the FUS200 led to a reduction in the number of cultures
of 58.3 and 37.4%, respectively. The reduction reported in other
studies with the UF-1000i varies from 28 to 64.5% (1, 9, 18, 22,
27). The reduction for the FUS200 in our study (37.4%) was lower
than the 65% found by Kocer et al. (5).
Automated systems provide the opportunity to analyse a large
number of samples in a short time. In our study, the UF-1000i
processed 66 samples per hour, and this is similar to the results
published by Pieretti et al. (22). However, the FUS200 was faster
and processed 120 samples per hour. We detected a difference
between the time described in the UF-1000i user’s manual and the
actual processing time. The difference was due to the time spent
to avoid carry-over. The UF-1000i has the option to configure
additional rinse cycles when high counts are detected in a sample.
Initially, this might be a disadvantage of the UF-1000i system
together with its limitation in processing samples with excess
mucus, gross haemolysis, or pyuria, but it guarantees no cross
contamination between samples.
Another issue that affects the productivity of the laboratory
is the maintenance time that will define the downtime for
the system (29). We ensured that both systems need similar
maintenance time. None of them can compete in terms of cost
against culture (cheaper but arduous and time-consuming). A
minimum difference of one cent of euro per sample between both
systems cannot be an argument for their selection. The rest of
the technical features verified, such as size, noise level, sample
volume, homogenized sample rate and consumables, showed no
significant differences between the UF-1000i and the FUS200
(data not shown). Another important concern is related with
the quality of samples that they admit. The UF-1000i does not
process samples with excess ofmucus, gross haemolysis or pyuria,
a limitation that was not found in the FUS200.
The selection of an ideal instrument for urine screening
depends on the characteristics of the laboratory, the level of
automation, the workload and efficient management (29). In
this scenario, the cost of consumables and performance (number
of samples per hour) will be of great importance for the
decision-making process. The number of samples processed per
hour should be enough to cover the daily peaks of growing
activity (30).
In conclusion and based on the AUC, cut-off value, number of
samples applied and maintenance time, our study shows that the
UF-100i and the FUS200 can be appropriate in a microbiology
laboratory, reducing unnecessary cultures and providing negative
results in few hours. At equal high sensitivity level (95%) the UF-
1000i showed higher specificity than the FUS200 instrument, but
the FUS200 needs a shorter processing time.
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